Abstract
Metabolic syndrome and diabetes lead to pathological angiogenesis and angiopathy. Metabolic disturbances occur as an effect of genetic and environmental interaction. Hyperleptinemia accompanies obesity and leptin is a potent proangiogenic factor. The aim of the study was to investigate the effect of high fat diet-induced alterations in gene expression and angiogenic response in the hRXRα ko mice lacking of hyperglycemia.
hRXRα ko and control mice were fed either standard or high saturated fat (HF) diet for 7 weeks. Body weight and biochemical parameters (glucose, triglycerides, cholesterol), insulin and adipokines (leptin, adiponectin) were monitored. At sixth week of feeding, mice were subcutaneously injected for 6 days with matrigel containing bFGF. Then, matrigel plugs were used for immunohistochemical staining of cells with CD31 antibody and gene expression assessment (by microarray confirmed for some genes with quantitative real time PCR). For description of angiogenesis CD31 positive structures were counted in the matrigel sections. HF diet feeding of the hRXRα ko mice resulted in increased serum cholesterol and leptin level and in tendency to decrease angiogenesis (number of vessels with lumen). The microarray studies revealed that HF diet down-regulated genes related to angiogenesis (Nos3, Kdr) and up-regulated genes connected with apoptosis (activators of caspase 3, proapoptotic genes Bcl2) and proinflammatory pathway (NfκB pathway, Tnfα).
Summing up, HF diet feeding of hRXRα ko mice resulted in dyslipidemia and hyperleptinemia as well as impaired angiogenic response, and cell apoptosis. These results argue for independent participation of dyslipidemia and hyperleptinemia in pathology of angiogenic response associating metabolic syndrome.
Keywords: angiogenesis, adipogenesis, apoptosis, metabolic syndrome, microarray, RXR α ko
Introduction
Obesity, metabolic syndrome and diabetes type 2 represent one of the dominating disorders of industrialized societies [17]. Metabolic disturbances occur as an effect of genetic background combined with the influence of environmental factors such as consumption of a high fat western diet. This results in a progressive development of obesity and insulin resistance (hyperglycemia, hyperinsulinemia), which are the main symptoms of metabolic syndrome (MS). One of the MS consequences is pathological angiogenesis that controls angiopathy such as retinopathy, nephropathy etc. [10, 22, 25].
Pathological angiogenesis is characterized by growth of new, leaky, immature blood vessels, which resemble primitive vascular network found in cancer [20] or atherosclerotic plaque [16]. Important role in the induction of this pathological angiogenesis play biochemical factors such as: dyslipidemia, modified lipoproteins (ox LDL), increased level of free fatty acids (FFA), insulin and insulin-like growth factor 1 (IGF-1), adipokines (leptin, adiponectin). Angiogenesis is also regulated by: pro-inflammatory cytokines (interleukins: IL-6, IL-8, tumor necrosis factor α (TNFα)), growth factors (vascular endothelial growth factor (VEGF), angiopoietin-1 and −2, stromal-derived factor-1 (SDF1), fibroblast growth factor-2 (bFGF) as well as pigmented epithelium derived growth factor (PEDGF)) or nitric oxide (NO) which concentrations are changed [7, 20, 23].
Retinoid X receptor α (RXR α) is a transcription factor, which regulates gene expression of enzymes participating in lipid (FFA biosynthesis as well as oxidation) and bile acid metabolism in the liver [29]. Thus, the hepatocyte RXRα deficient mice are a unique model for studying selected symptoms of metabolic syndrome, characterized by elevation of FFA in the blood [31–33]. Mice with RXRα deficiency in hepatocytes (hRXRα ko), including young ones, demonstrate elevated serum triglycerides concentration and increased apoCIII mRNA amounts [31]. Glucose and insulin concentrations do not differ between knockout and control wild type mice, when hRXRa ko mice develop hypercholesterolemia and hyperleptinemia upon feeding them high fat (HF) diet. There is some evidence that increased glucose tolerance in hRXRα ko mice fed with HF diet is associated with the increased expression of IGF1 [33].
The aim of the study was to investigate how the selected diet-induced alterations in hRXRα ko mice metabolism such as dyslipidemia and hyperleptinemia with normal blood glucose and insulin concentrations may impact angiogenic response.
Materials and Methods
Animals and experimental conditions
The study protocol was reviewed and approved by the Local University Ethic Committee in Kraków (No. 58/OP/2003). All experiments were performed according to Polish laws and approved by the Polish Animal Inspectorate and Institutional Animal Care.
Control wild type mice (WT) and hepatocyte RXR α deficient mice (hRXRα ko) were kindly provided by Dr. Yu-Jui Yvonne Wan (University of Kansas Medical Center, Kansas City, Kansas), who generated hepatocyte specific RXRα deficient mice [32].
Male mice, which were 15 week old and weighted 29–35 g, were housed in cages at 22°C with 12-h light, 12-h dark cycle and had free access to food and water. Wild type and knockout animals were fed either standard lab chow containing about 9 energy percent (9 en%) of fat (3% weight of the diet) or high saturated fat diet (HF, coconut oil hydrogenated based, 39 en% of fat) (20% weight of the diet) (MP Biomedical Research, USA) for 7 weeks. The animals were weighted twice a week.
Blood samples were collected from the tip of tails once a week (after 4 h of starvation). Serum biochemical parameters (glucose, cholesterol, triglycerides) were measured using Cormay Diagnostic Kits (Poland). Serum leptin level was determined using Anti Mouse ELISA Kit (R&D). Insulin was measured with Elisa Kit (Linco Research).
The in vivo model of angiogenesis
The angiogenesis model was introduced in the WT as well as hRXRα ko animals following six weeks of standard or HF diet. Mice were injected subcutaneously in the dorsal region with two sterile injections of 500 µl matrigel (Becton Dickinson) containing bFGF [25 nM]. Six days later, matrigel plugs were removed under anesthesia and they were used for endothelial cell immunohistochemistry (immunostaining of CD31 PECAM1-positive cells) and analysis of gene expression in the infiltrating matrigel plug cells [30, 35].
Immunohistochemical studies were carried out in the matrigel plugs fixed in Zinc-Fixative (Becton Dickinson) and immersed in paraffin. The endothelial cells infiltrating matrigel were visualized with antibodies specific for CD31 antigen in paraffin embedded matrigel sections. The primary rat anti-mouse CD31 antibodies (anti-PECAM1, Becton Dickinson) at 1:300 dilution were used. The slides were rehydrated and incubated in 3% peroxide solution for 10 min to block endogenous peroxidase activity. The Streptavidin-Biotin (BD Pharmingen) detection system with visualization by Anti-Rat HRP Detection Kit (Becton Dickinson) was used. The matrigel sections were contra-stained with Meyer hematoxylin (DAKO, Denmark). Blood capillaries that had formed in the matrigel plugs were counted under microscope by an uninformed pathologist, who used a “hotspot” method to visually inspect five different fields in three slides taken from different parts of each plug. The previously described method of microvessel evaluation in the vasculature “hotspots” was applied [34].
Analysis of gene expression in the matrigel plug cells
Microarray
RNA from the cells that had migrated into the matrigel plugs was isolated using TRIZOL Reagent (Invitrogen Life Technologies) and purified with QIAamp RNA Blood Mini Kit for total RNA isolation (Qiagen). High quality of the isolated RNA was confirmed by its analysis on the Agilent 2100 Bioanalyzer (Agilent Technologies).
The effects of HF diet on the gene expression in the cells found in the matrigel plugs removed from the knockout and control mice were screened by the microarray assays. RNA was transcribed into cDNA using Superscript II (Invitrogen Life Technologies) with a primer containing T7 promoter. cDNA was used as a template for transcription reaction (Enzo BioArray, Affymetrix). The target cRNA was purified on RNeasy columns (Qiagen), then fragmented for hybridization to Affymetrix 430A_2 GeneChips (containing 22,691 spots for estimation of 14,000 genes from mice genome). Hybridization was carried out at 45°C for 16 h in the GeneChip Hybridization Oven 640 (Affymetrix). The GeneChips were scanned with the Hewlett Packard GeneArray Scanner and results were analyzed with Affymetrix Microarray Analysis Suit. Only spots that demonstrated significant differences in signal intensities were considered (p < 0.05).
Changes in the relative gene expression in the matrigel infiltrating cells derived from the hepatocyte RXR α knockout mice compared to wild type animals (pooled material from 3 matrigel plugs) were calculated with GCOS 1.4 computer software (Affymetrix). The microarray results were presented as relative gene expression values (fold of change). Only genes in which fold of change was greater than 1.4 were used for further analysis.
Confirmation of the selected microarray indicated gene expression by the quantitative realtime PCR (qRT-PCR)
A limited number of genes, which expression was significantly altered during microarray analysis, was further monitored by qRT-PCR with Gapdh as the reference gene. The mostly affected genes, which corresponded to angiogenesis, adipogenesis, energy expenditure, and glucose metabolism, were chosen. Expression of the genes associated with angiogenesis (VEGF receptor 2: Kdr, endothelial nitric oxide synthase: Nos3, platelet endothelial cell adhesion molecule-1: Pecam1), adipogenesis (adipsin: Adn, fatty acid binding protein 4: Fabp4, lipoprotein lipase: Lpl, CCAAT/ enhancer binding protein (C/EBP) β: Cebpb, sterol regulatory element binding factor 1: Srebf1), energy expenditure (uncoupling protein 2 (mitochondrial, proton carrier): Ucp2) and glucose uptake (solute carrier family 2 (facilitated glucose transporter), member 4: Slc2a4) was confirmed by real time PCR.
One microgram of total RNA for cDNA synthesis was reverse transcribed in a total volume of 40 µl reaction buffer containing 5 × First Strand Buffer, DTT, oligo(dT) (Sigma), deoxy-NTPs (Promega) and 200 units of SUPERSCRIPT II reverse transcriptase (Invitrogen Life Technologies) at 42°C for 50 min. The mixture was heated to 70°C for 15 min and immediately chilled on ice. Then, cDNA was subjected to real time PCR in a reaction mixture containing QuantiTect SYBR Green PCR (Qiagen) mix and primers. The primers had intervening intron between the sense and antisense primers to eliminate possibility of amplifying any genomic DNA. The primers were checked for specificity by BLAST searches (Tab. 1). The thermal profile of the PCR reaction included initial denaturation for 15 min at 95°C, followed by 40 amplification cycles of denaturation for 30 s at 94°C, annealing for 30 s at 60°C, and elongation for 30 s at 72°C. Melting curve analysis was performed after PCR amplification with a temperature profile slope of 1°C/s from 35°C to 95°C. The expression rates were calculated as the normalized CT difference between a control probe and a sample with the adjustment for the amplification efficiency relative to the expression level of the housekeeping gene Gapdh (glyceraldehyde 3-phosphate dehydrogenase). Calculations were performed using a software program Calculation Matrix for PCR Efficiency REST-XL.
Tab. 1.
List of primers used in qRT-PCR
| Gene symbol | mRNA sequence | Forward primer | Reverse primer |
|---|---|---|---|
| Gapdh | NM_08084 | 5’tcaccaccatggagaaggc3’ | 5’acacccatcacaaacatgg3’ |
| Fabp4 | NM_24406 | 5’ggatggaaagtcgaccacaat3’ | 5’gtggaagtcacgcctttcata3’ |
| Lpl | NM_08509 | 5’cctgaagactcgctctcagat3’ | 5’ggttgtgttgcttgccatt3’ |
| Cebpb | NM_09883 | 5’ttcctctccgacctcttcg3’ | 5’ggccgaggctcacgtaac3’ |
| Srebf1 | NM_11480 | 5’gagcttccggcctgctat3’ | 5’tcagactgcgatccaggag3’ |
| Adn | NM_13459 | 5’cattaacatgatgtgtgcagaga3’ | 5’cacgtaaccacaccttcgac3’ |
| Ucp2 | NM_11671 | 5’ggtcactgtgcccttaccat3’ | 5’ccaagcggagaaaggaag3’ |
| Slc2a4 | NM_09204 | 5’ggcatgggtttccagtatgt3’ | 5’agatgaagaagccaagcagg3’ |
| Kdr | NM_10612 | 5’tgcctacctcacctgtttcc3’ | 5’ctctttcgcttactgttctggag3’ |
| Nos3 | NM_08713 | 5’tgcagagaattctggcaaca3’ | 5’gtggtagcgttgctgatcc3’ |
| Pecam1 | NM_08816 | 5’gccagtagcatcatggtcaa3’ | 5’ccaacaactccccttggtc3’ |
Statistical analysis
All results were shown as the mean value ± standard deviation (SD). Analysis of differences was performed with Student t-test and p < 0.05 was considered as significant.
Results
Effect of HF diet on serum biochemical parameters
Mice hRXRα ko fed for 7 weeks with the high saturated fat diet had significantly higher serum leptin (Fig. 1) and cholesterol in comparison to the WT mice (Fig. 2). HF diet resulted in the increase of insulin and glucose in the wild type as well as mutant animals without any significant differences between genotypes. However, hRXRα ko mice did not develop obesity on HF diet (data not shown).
Fig 1.
Serum leptin of wild type (WT) and hepatocyte RXR α−/−mice (hRXRa ko) fed standard (STD) and high saturated fat diet (HFD). Values are expressed as the mean ± SD (n = 5), statistical significance of the differences: * p < 0.05, hRXRa ko on HFD vs. WT; # p < 0.05, hRXRa ko on HFD vs. STD
Fig 2.
Serum cholesterol of wild type (WT) and hepatocyte RXR α−/− mice (hRXRa ko) fed standard (STD) and high saturated fat diet (HFD). Values are expressed as the mean ± SD (n = 5), statistical significance of the differences: * p < 0.05, hRXRa ko on HFD vs. WT; # p < 0.05, hRXRa ko on HFD vs. STD
Influence of HF diet feeding on angiogenesis
Quantitative analysis of CD31 (PECAM1) positive structures in the matrigel plugs demonstrated that hRXRα ko showed tendency for weaker angiogenic response (formation of vessels with lumen) than wild type mice, especially after the HF feeding (Fig. 3).
Fig 3.
Number of vessels with lumen in matrigel plug of wild type mice and RXRα −/− mice (hRXRa ko) fed standard (STD) and high saturated fat diet (HFD). Values are expressed as the mean ± SD. (n = 5)
Gene expression in matrigel plug cells-microarray analysis
The microarray analysis revealed down-regulation of 963 and up-regulation of 1196 genes in hRXRα ko mice, whereas 1246 genes were down-regulated and expression of 1238 genes was up-regulated in WT mice. The significantly regulated genes were associated with angiogenic response, apoptosis, inflammatory response, oxidative stress, triglyceride synthesis, gluconeogenesis and with transcription factors related to adipogenesis (Tab. 2).
Tab. 2.
Comparison of microarray changes in relative gene expression (between matrigel plug cells from mice fed standard diet (ST) and matrigel plug cells from mice fed high saturated fat diet (HF)) in RXR α deficient mice (hRXRα ko) and WT mice in pathways connected with angiogenesis, apoptosis, adipogenesis, glucose and triglycerides synthesis, eicosanoid synthesis and oxidative stress response.
| Gene/Pathway Name | Symbol | WT HF vs. ST | hRXRa ko HF vs. ST |
|---|---|---|---|
| CELL CYCLE | |||
| cyclin B1 | Ccnb1 | −1.87 | |
| cell division cycle 2 homolog A (S. pombe) | Cdc2a | 1.74 | −1.62 |
| origin recognition complex, subunit 4-like (S. cerevisiae ) | Orc4l | 1.74 | −2.00 |
| origin recognition complex, subunit 6-like (S. cerevisiae ) | Orc6l | n. c. | −2.00 |
| replication protein A3 | Rpa3 | n. c. | −2.00 |
| cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase) | Cdk7 | n. c. | −3.48 |
| DNA primase, p49 subunit | Prim1 | 1.52 | −1.41 |
| DNA primase, p58 subunit | Prim2 | n. c. | −3.73 |
| cyclin D3 | Ccnd3 | −1.74 | 1.32 |
| cyclin D2 | Ccnd2 | −1.41 | n. c. |
| transformation related protein 53 | Trp53 | −2.14 | n. c. |
| cyclin-dependent kinase inhibitor 1A (P21) | Cdkn1a | −1.87 | n. c. |
| minichromosome maintenance deficient 3 (S. cerevisiae ) | Mcm3 | 1.62 | n. c. |
| minichromosome maintenance deficient 6 (MIS 5 homolog, S. pombe) (S. cerevisiae) | Mcm6 | 2.30 | n. c. |
| minichromosome maintenance deficient 7 (S. cerevisiae ) | Mcm7 | 1.87 | n. c. |
| cyclin A2 | Ccna2 | 1.32 | n. c. |
| 3-monooxygenase/tryptophan 5-monooxygenase activation protein, γ polypeptide | Ywhag | 2.46 | −2.64 |
| CELL ADHESION | |||
| integrin α M | Itgam | −4.59 | 2.30 |
| integrin α X | Itgax | −1.62 | 1.74 |
| integrin β 2 | Itgb2 | −3.73 | 1.41 |
| integrin β 7 | Itgb7 | −1.32 | 3.73 |
| procollagen, type XI, α1 | Col11a1 | n. c. | −42.22 |
| procollagen, type III, α1 | Col3a1 | 4.29 | −1.41 |
| procollagen, type IV, α1 | Col4a1 | 6.50 | −2.14 |
| procollagen, type V, α 2 | Col5a2 | 1.62 | −1.52 |
| procollagen, type VIα2 | Col6a2 | 2.83 | 1.52 |
| matrix metallopeptidase 9 | Mmp9 | n. c. | 3.73 |
| matrix metallopeptidase 12 | Mmp12 | −2.00 | 1.87 |
| gap junction membrane channel protein α 1 | Gja1 | n. c. | −1.41 |
| gap junction membrane channel protein α 4 | Gja4 | n. c. | −1.74 |
| gap junction membrane channel protein β 5 | Gjb5 | n. c. | −2.46 |
| kinase insert domain protein receptor | Kdr | n. c. | −1.87# |
| platelet derived growth factor receptor, β polypeptide | Pdgfrb | n. c. | −1.52 |
| nitric oxide synthase 3, endothelial cell | Nos3 | n. c. | −2.64# |
| integrin α 9 | Itga9 | −2.46 | n. c. |
| integrin α 5(fibronectin receptor α) | Itga5 | −3.48 | n. c. |
| integrin β 1 (fibronectin receptor β) | Itgb1 | −1.52 | n. c. |
| laminin, α 2 | Lama2 | 7.46 | n. c. |
| laminin, α 4 | Lama4 | 2.30 | n. c. |
| laminin B1 subunit 1 | Lamb1-1 | 2.64 | n. c. |
| laminin, β 2 | Lamb2 | 2.00 | n. c. |
| procollagen, type IV, α 2 | Col4a2 | 3.25 | n. c. |
| procollagen, type V, α 1 | Col5a1 | 2.14 | 1.52 |
| procollagen, type I, α 1 | Col1a1 | 2.00 | n. c. |
| APOPTOSIS | |||
| perforin 1 (pore forming protein) | Prf1 | −4.29 | 2.14 |
| granzyme B | Gzmb | −5.66 | 9.85 |
| BCL2-like 11 (apoptosis facilitator) | Bcl2l11 | −1.87 | 1.41 |
| nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, ε | Nfkbie | −2.14 | 4.00 |
| nuclear factor of κ light chain gene enhancer in B-cells 1, p105 | Nfkb1 | −1.32 | 1.52 |
| nuclear factor of κ light chain gene enhancer in B-cells inhibitor, α | Nfkbia | −1.52 | 1.32 |
| tumor necrosis factor receptor superfamily, member 21 | Tnfrsf21 | −1.52 | 2.00 |
| tumor necrosis factor receptor superfamily, member 1b | Tnfrsf1b | −2.14 | 1.87 |
| caspase 3 | Casp3 | −1.62 | n. c. |
| caspase 6 | Casp6 | −1.74 | n. c. |
| baculoviral IAP repeat-containing 5 | Birc5 | n. c. | −1.41 |
| baculoviral IAP repeat-containing 4 (Birc4), mRNA | Birc4 | n. c. | −1.52 |
| OXIDATIVE STRESS RESPONSE | |||
| heme oxygenase (decycling) 1 | Hmox1 | −1.62 | −4.92 |
| glutamate-cysteine ligase, catalytic subunit | Gclc | n. c. | −1.74 |
| glutathione reductase 1 | Gsr | n. c. | −2.00 |
| microsomal glutathione S-transferase 1 | Mgst1 | 2.83 | −1.74 |
| EICOSANOID SYNTHESIS | |||
| prostaglandin-endoperoxide synthase 1 | Ptgs1 | n. c. | 2.46 |
| prostaglandin I2 (prostacyclin) synthase | Ptgis | −2.14 | 1.52 |
| leukotriene C4 synthase | Ltc4s | −2.00 | 1.62 |
| prostaglandin E synthase | Ptges | −1.87 | 1.62 |
| arachidonate 15-lipoxygenase | Alox15 | n. c. | 3.25 |
| arachidonate 5-lipoxygenase activating protein | Alox5ap | −1.52 | n. c. |
| prostaglandin-endoperoxide synthase 2 | Ptgs2 | −3.03 | n. c. |
| GLUCOSE METABOLISM | |||
| solute carrier family 2 (facilitated glucose transporter), member 4 | Slc2a4 | −2.14# | 2.64 |
| solute carrier family 2 (facilitated glucose transporter), member 1 | Slc2a1 | −3.25 | 2.30 |
| hexokinase 1 | Hk1 | −1.87 | 2.30 |
| hexokinase 2 | Hk2 | −1.74 | 2.64 |
| glucose phosphate isomerase 1 | Gpi1 | −1.62 | 1.52 |
| phosphofructokinase, muscle | Pfkm | −2.64 | 6.50 |
| phosphofructokinase, liver, B-type | Pfkl | −1.32 | 1.74 |
| phosphofructokinase, platelet | Pfkp | −1.52 | 1.52 |
| Aldolase 1, A isoform (Aldoa), mRNA | Aldoa | −1.62 | 1.87 |
| aldolase 3, C isoform | Aldoc | −2.30 | n. c. |
| triosephosphate isomerase 1 | Tpi1 | −1.32 | 1.41 |
| phosphoglycerate mutase 1 | Pgam1 | −1.41 | n. c. |
| phosphoglycerate mutase 2 | Pgam2 | −4.92 | 34.30 |
| pyruvate kinase, muscle | Pkm2 | −1.41 | n. c. |
| enolase 3, β muscle | Eno3 | −3.25 | 17.15 |
| enolase 2, neuronal | Eno2 | n. c. | 6.50 |
| phosphatidylinositol 3-kinase catalytic | Pik3cd | −1.52 | 1.52 |
| muscle glycogen phosphorylase | Pygm | −4.92 | 51.98 |
| UDP-glucose pyrophosphorylase 2 | Ugp2 | 1.41 | 1.62 |
| phosphorylase kinase α 1 | Phka1 | −17.15 | 2.00 |
| forkhead box O1 | Foxo1 | n. c. | 1.52 |
| forkhead box O3a | Foxo3a | n. c. | 1.41 |
| protein kinase C, β 1 | Prkcb1 | n. c. | 1.62 |
| protein kinase C, δ | Prkcd | −1.74 | 1.52 |
| protein kinase C, ζ | Prkcq | n. c. | 5.28 |
| TRIGLYCERIDE SYNTHESIS | |||
| glycerol-3-phosphate dehydrogenase 1 (soluble) | Gpd1 | n. c. | 2.14 |
| glyceronephosphate O-acyltransferase | Gnpat | n. c. | 1.52 |
| diacylglycerol O-acyltransferase 1 | Dgat1 | −1.62 | n. c. |
| lipoprotein lipase | Lpl | 3.03# | n. c. |
| ADIPOGENESIS | |||
| CCAAT/enhancer binding protein (C/EBP), β | Cebpb | −3.48# | 1.74# |
| sterol regulatory element binding factor 1 | Srebf1 | n. c. | 1.74# |
| adiponectin, C1Q and collagen domain | Adipoq | 3.73 | −6.96 |
| resistin | Retn | n. c. | −6.06 |
| adipsin | Adn | 7.46# | −13.00# |
| fatty acid binding protein 4, adipocyte | Fabp4 | 1.62 | −4.92# |
| lipoprotein lipase | Lpl | 3.03# | n. c. |
Microarray analysis of angiogenic gene expression
Diet high in saturated fat differentially regulated expression of the genes that affected angiogenic response associated with: cell cycle, adhesion, and matrix remodeling in ko mice and their wild type controls.
According to the recent monographic data that address proangiogenic activity of the endothelial cells, special attention was paid to the HF diet-regulated genes involved in the cell cycle and proliferation. Our study indicated that HF diet led to inhibition of the cell cycle G2/M phase gene expression (cyclins and cycline dependent kinases: Ccnb1, Cdc2a) and activation of G2/M phase inhibitor gene expression Ywhag in the matrigel plug cells from hRXRα ko mice. Inhibition of expression of the genes participating in DNA replication in G1 phase of cell cycle (Orc4L, Orc6L, Rpa3, Cdk7, Prim1, Prim2) was also observed.
In comparison, the HF diet resulted in downregulation of the cell cycle G1 phase genes (Ccnd3 and Ccnd2) and genes that encoded such inhibitors of cell cycle as p53 (Trp53) and p21 (Cdkn1a) in the cells infiltrating the matrigel plugs of WT mice. Some genes that affected DNA replication (Mcm3, Mcm6, Mcm7, Orc4L) were activated. In addition, upregulation of cyclins and kinases of G2 phase (Ccna2 and Cdc2a) as well as inhibition of expression of an inhibitor of G2 phase (Ywhag gene) was found.
Adhesion plays an important role in the contact inhibition of endothelial cell proliferation, vessel permeability and leukocyte migration. Regulation of adhesion is also required for a correct organization of new vessels in network [27]. Microarray studies of the cells from the matrigel plugs from hRXRα ko mice fed HF diet pointed to activation of genes encoding integrins participating in cell – matrix interactions (Itgam, Itgax, Itgb2, Itgb7), as well as inhibition of expression of the matrix protein genes such as collagens (Col11a1, Col3a1, Col4a1, Col5a2). Some of the genes encoding matrix metaloproteinases (Mmp9, Mmp12) were up-regulated. Moreover, inhibition of gap junction gene expression (Gja1, Gja4, Gjb5) was observed. Additionally, analysis of the cells infiltrating matrigel plugs from hRXRα ko mice maintained on the HF diet demonstrated down-regulation of the growth factor receptors genes such as VEGF receptor 2 (Kdr) and PDGF receptor (Pdgfrb), which activation played an important role in angiogenesis inducing proliferation and migration of endothelial cells. Gene expression of endothelial nitric oxide synthase (Nos3), an enzyme responsible for vasodilatation, endothelial cell protection and angiogenesis, was also inhibited.
In WT mice fed with HF diet, inhibition of genes encoding integrins (Itgam, Itgax, Itga9, Itga5, Itgb1, Itgb2) and activation of laminin (Lama2, Lama4, Lamb1-1, Lamb2) and collagen (Col3a1, Col4a1, Col4a2, Col5a1, Col5a2, Col6a2, Col1a1) gene expression was the main effect observed in the cells from the matrigel plugs.
Influence of HF diet on metabolic gene expression
The RXRα/PPARα heterodimer regulates expression of genes responsible for fatty acid metabolism in the liver [4, 11]. The hRXRα ko animals demonstrated a decreased expression pattern of genes responsible for liver fatty acid metabolism, what could explain the increased amount of fatty acids in the circulation and subsequently lipotoxicity and apoptosis of tissue cells [3]. As expected, the HF diet led to activation of apoptosis-related genes in the matrigel cells from the hRXRα ko, but not in WT mice. Genes encoding activators of caspase 3 (Prf1, Gzmb), pro-apoptotic genes Bcl2 (Bcl2L11), NFκB pathway (Nfkbie, Nfkb1), and TNFα receptors (Tnfrsf21, Tnfrsf1b) were up-regulated, while apoptosis inhibitors genes (Birc5, Birc4) were down-regulated. Opposite effects were observed in the matrigel plug cells from WT control mice. Expression of the genes encoding caspase activators (Prf1, Gzmb), Bcl2 (Bcl2L11), NFκB (Nfkbie, Nfkbia), caspases (Casp3, Casp6), TNFα (TNfrsf21, Tnfrsf1b) was decreased.
Additionally, the HF diet down-regulated expression of genes that affected detoxification processes such as heme oxygenase 1 (Hmox1), glutamatecysteine ligase (Gclc), glutathione reductase (Gsr), microsomal glutathione S-transferase 1 (Mgst1) pointing to an increased lipotoxicity in the hRXRα ko mice. In contrast, the above genes were up-regulated in the control animals.
It was previously reported that feeding with HF diet induced expression of the eicosanoid generating enzymes [19]. Prostanoids were proposed to be potent adipogenic substances that activated of PPARγ [15], while HF diet promoted adipogenesis [17]. Our microarray studies in the cells from matrigel plugs from the hRXRα ko mice fed HF diet demonstrated upregulation of the prostaglandin-endoperoxide synthase 1 (Ptgs1), prostaglandin I2 (prostacyclin) synthase (Ptgis), leukotriene C4 synthase (Ltc4s), prostaglandin E synthase (Ptges), as well as arachidonate 15-lipoxygenase (Alox15). On the contrary, results in the control WT mice fed with HF diet indicate down- regulation of the genes related to the eicosanoid synthesis, including prostaglandin I2 (prostacyclin) synthase (Ptgis), prostaglandin E synthase (Ptges), leukotriene C4 synthase (Ltc4s), arachidonate 5-lipoxygenase activating protein (Alox5ap), as well as prostaglandin-endoperoxide synthase 2 (Ptgs2). Also, expression of the genes that control substrate accumulation in the cells were differentially regulated by HF in the matrigel cells from the hRXRα ko mice and their WT counterparts. In this case, glycerol-3-phosphate dehydrogenase 1 (Gpd1) and glycerol phosphate O-acyltransferase (Gnpat) genes expression related to triglyceride synthesis were stimulated in the cells harvested from the matrigel plugs of the hRXRα ko mice. The WT mice responded to the HF diet with downregulation of diacylglycerol O-acyltransferase 1 (Dgat1) and upregulation of lipoprotein lipase (Lpl).
The HF diet activated expression of transcription factors important for adipogenesis in the cells from the hRXRα ko mice. Essential for adipogenesis transcription factors [6] such as CCAAT/enhancer binding protein (C/EBP) β (Cebpb), sterol regulatory element binding factor 1 (Srebf1) were up-regulated, but markers of differentiated adipocytes, such as adiponectin (Adipoq), resistin (Retn), adipsin (Adn) and fatty acid binding protein (Fabp4), were downregulated. Surprisingly, the HF diet down-regulated gene expression of a transcription factor that affected pre-adipocyte differentiation (Cebpb), whereas genes related to differentiated adipocytes: adiponectin (Adipoq), adipsin (Adn), fatty acid binding protein 4 (Fabp4), lipoprotein lipase (Lpl) were up-regulated in the WT mice.
Genes related to glucose metabolism were also differentially regulated in our mouse models by HF diet. In the hRXRα ko mice, gene expression of glucose transporters Glut4 (Slc2a4), Glut1 (Slc2a1) and several genes involved in glycolysis, including hexokinase 1 (Hk1), hexokinase 2 (Hk2), glucose phosphate isomerase 1 (Gpi1), phosphofructokinase, muscle (Pfkm), phosphofructokinase, liver, B-type (Pfkl), platelet phosphofructokinase (Pfkp), aldolase 1, Aisoform (Aldoa), triosephosphate isomerase 1 (Tpi1), phosphoglycerate mutase 2 (Pgam2), muscle β enolase 3, (Eno3), neuronal enolase 2, γ (Eno2) were upregulated by the high saturated fat diet. Activation of PI3K genes (phosphatidylinositol 3-kinase catalytic δ polypeptide, Pik3cd), and genes encoding proteins involved in glycogen turnover, such as muscle glycogen phosphorylase (Pygm), UDP-glucose pyrophosphorylase 2 (Ugp2) and phosphorylase kinase α 1 (Phka1), was also observed. In addition, transcription factors involved in insulin signaling (Foxo1, Foxo3a) and modulators of insulin action (protein kinases c Prkcb1, Prkcd, Prkcq) were up-regulated.
On the contrary, the HF diet in the matrigel cells harvested from the WT mice caused an overall down-regulation of the genes encoding glucose transporters Glut4 (Slc2a4), Glut1 (Slc2a1), genes involved in glycolysis (hexokinase 1 (Hk1), hexokinase 2 (Hk2), phosphofructokinase, muscle (Pfkm), phosphofructokinase, platelet (Pfkp), aldolase 1, A isoform (Al-doa), aldolase 1, C isoform (Aldoc), phosphoglycerate mutase 2 (Pgam2), phosphoglycerate mutase 1 (Pgam1), enolase 3, β muscle (Eno3), pyruvate kinase, muscle (Pkm2)) and catabolism of glycogen (Pygm, Phka1). The genes associated with signal transduction from insulin receptor was also downregulated in WT mice by HF diet.
Quantitative real time-PCR results
Direction of changes in expression of the adipogenesis and angiogenesis related genes in response to the HF diet in the cells from matrigel plugs from the two mouse models was in agreement with the microarray screening. The qRT-PCR results confirmed inhibition of the critical for angiogenesis markers of endothelial cells proliferation genes (Kdr, Nos3) in the cells from the hRXRα ko mice fed HF diet. Also, inhibition of expression of the gene markers for differentiated adipocytes (Fabp4, Adn) and up-regulation of the genes related to early differentiation of adipocytes (Cebpb, Srebf1) were observed (Tab. 2, Fig. 4).
Fig 4.
Real time PCR confirmation of microarray changes in relative gene expression (between matrigel plug cells from mice fed standard diet (ST) and matrigel plug cells from mice fed high saturated fat diet (HF)) in RXR α deficient mice (hRXRα ko) and WT mice in pathways connected with angiogenesis (VEGF receptor 2: Kdr, endothelial nitric oxide synthase: Nos3. platelet endothelial cell adhesion mole-cule-1: Pecam1), adipogenesis (adipsin Adn, fatty acid binding protein 4: Fabp4, lipoprotein lipase: Lpl, CCAAT/ enhancer binding protein (C/EBP) β Cebpb, sterol regulatory element binding factor 1: Srebf1), energy expenditure (uncoupling protein 2 (mitochondrial proton carrier): Ucp2) and glucose uptake (solute carrier family 2 (facilitated glucose transporter), member 4: Slc2a4). Gapdh was used as reference gene
Regulation of the gene expression in the matrigel plug cells of the WT mice fed with HF diet was in accordance with the microarray results concerning angiogenesis (down-regulation of Kdr and Nos3), adipogenesis (up-regulation of Lpl, down-regulation of Cebpb), glucose uptake (inhibition of glucose transporter Glut4 (Slc2a4)) (Tab. 2).
Discussion
In the presented study, the hRXRα ko mice maintained on the HF diet demonstrated significantly elevated amounts of serum cholesterol and leptin without developing obesity, what is characteristic for this experimental model and remains in contrast to the WT mice [4, 29, 31–33]. Our observations might be due to peripheral lipotoxicity [28], increased energy expenditure (enhanced UCP2 mRNA level, observed also in our RT-PCR results) and/or decreased angiogenesis [7, 18, 23]. Our results indicated that the hRXRα ko mice on the HF diet, despite increased amounts of proangiogenic leptin [21] in serum, demonstrated tendency to decreased angiogenic response and capillary network differentiation (lumen formation) in our matrigel model of angiogenesis. The microarray results confirmed inhibition of the important angiogenesisrelated genes in the cells isolated from these mice. On the contrary, activation of the genes related to the early steps of adipogenesis but not the final adipocyte differentiation, was observed in the matrigel cells of the hRXRα ko animals fed with the HF diet. For example, down-regulation of Kdr, the receptor for VEGF, and inhibition of endothelial nitric oxide synthase (Nos3) genes expression were observed in the microarray and qRT-PCR studies. Both VEGFA and NO play important roles in angiogenesis by promoting endothelial cells proliferation and vascular network formation [1, 5, 23].
Inhibition of the early angiogenic response was also supported by the microarray studies, where decreased expression of the genes encoding gap junction proteins, matrix remodeling enzymes along with up-regulation of the genes indicative of lipotoxicity and/or apoptosis activation were found.
In the hRXRα ko mice, impaired fatty acid utilization in the liver and subsequently endothelial exposure to dyslipidemia lead to endothelial dysfunction, lipotoxicity and oxidative stress [8, 13]. It was shown, that free fatty acids (FFAs), PPARs’ activators, inhibited angiogenesis in in vitro studies [12]. Our analysis of the gene expression in the cells in the matrigel plug of hRXRα ko animals revealed up-regulation of the genes involved in the triglyceride synthesis (Gpd1, Gnpat). An excess of FFAs may lead to lipotoxicity of endothelium by increased de novo synthesis of diacylglycerol [14], which activates isoforms of protein kinase C (PKC) and leads to stimulation of endothelial superoxide production by NAD(P)H oxidase, inhibition of endothelial NO synthase activity and activation of NF-κB and proinflammatory pathway [9]. In our microarray study, we indeed observed activation of PKC gene expression parallel with inhibition of the antioxidant genes (Hmox1, Gdc, Gsr, Mgst1), inhibition of Nos3 and up-regulation of proinflammatory pathways NFκB (Nfkbie) and TNFα receptors (Tnfrsf21, Tnfrsf1b) in the knockout mice on the HF diet. FFA induced endothelial lipotoxicity and utilization of glucose as a source of energy as evidenced by up-regulation of the genes encoding glycogenolysis enzymes, Glut4 (Slc2a4) and Glut1 (Slc2a1) transporters and activation of glucose/cell cycle related transcription factors (Foxo1, Foxo3).
Additionally, our microarray analysis verified activation of the pro-apoptotic genes that might impair angiogenic response in the cells of the knockout mice on the HF diet. Increase of caspase 3 activity through Prf1, Gzmb, up-regulation of proapoptotic protein Bcl2 (Bcl2L11) and inhibition of anti-apoptotic proteins gene expression (Birc4, Birc5) argued for activated apoptosis [26]. On the contrary, expression of the apoptotic genes such as: caspase activators (Prf1, Gzmb), caspases (Casp3, Casp6) was down-regulated by the HF diet in the control mice.
Microarray analysis as well as quantitative real time PCR results also indicated that beside downregulation of the pro-angiogenic genes, the HF diet activated transcription factors related to early adipogenesis such as Srebf1, Cebpb [6] in the cells that formed primitive vessel networks in the matrigel from the hRXRα ko mice, what was also in agreement with the increased amounts of serum leptin in these mice. However, this adipokine was also reported to inhibit maturation of the adipocytes [2].
Scarfo et al. [24] documented that arachidonic acid and its metabolites induced genes of enzymes involved in eicosanoid synthesis, what was associated with formation of cellular lipid droplets. The expression of the enzymes participating in the eicosanoid synthesis was up-regulated in the presented study. The amounts of mRNA encoding prostaglandin-endoperoxide synthase 1 (Ptgs1), prostaglandin I2 (prostacyclin) synthase (Ptgis) and arachidonate 15-lipoxygenase (Alox15) were significantly increased in the cells migrating to the hRXRα ko animals. Previously, it was shown that eicosanoids potentiated adipocyte differentiation by activating PPARγ [15]. The well known effect of angiogenesis inhibition by PPARγ activators [12] was in agreement with the obtained results.
In summary, HF diet resulted in dyslipidemia and hyperleptinemia, inhibition of the angiogenic response, and activation of adipogenesis in the cells migrating to the matrigel plugs in the hepatocyte RXR α deficient mice. Inhibition of angiogenesis might also result from increased apoptosis of the new capillary network forming cells. These results may add to the multifactorial background of pathological angiogenesis observed in diabetes.
Acknowledgments
We would like to thank Dr. Anna Knapp for kind help in preparation of this paper. Supported by Polish Committee of Science Grant No. PBZ-MIN-005/P04/2002/5, National Institutes of Health grants CA53596, AA14147, and COBRE P20 RR021940, the Molecular Biology Core under COBRE as well as the Liver Center at KUMC.
Abbreviations
- Adn
adipsin
- apoCIII
apolipoprotein CIII
- bFGF
fibroblast growth factor-2
- Cebpb
CCAAT/enhancer binding protein (C/EBP) β
- DNA
deoxyribonucleic acid
- Fabp4
fatty acid binding protein 4
- FFAs
free fatty acids
- Gapdh
glyceraldehyde 3-phosphate dehydrogenase
- HF
high fat diet
- hRXRα ko
hepatocyte retinoid X receptor α deficient
- IGF-1
insulin-like growth factor 1
- Kdr
VEGF receptor 2
- MS
metabolic syndrome
- Lpl
lipoprotein lipase
- LXR α
liver X receptor α
- NFκB
nuclear factor κB
- NO
nitric oxide
- Nos3
endothelial nitric oxide synthase
- ox LDL
oxidized low density lipoproteins
- PCR
polymerase chain reaction
- Pecam1
platelet endothelial cell adhesion molecule-1
- PEDGF
pigmented epithelium derived growth factor
- PPARs
peroxisome proliferator activated receptors
- qRT-PCR
quantitative real-time PCR
- RNA
ribonucleic acid
- RXRα
retinoid X receptor α
- SDF1
stromal-derived factor-1
- Slc2a4
solute carrier family 2 (facilitated glucose transporter), member 4
- Srebf1
sterol regulatory element binding factor 1
- TNFα
tumor necrosis factor α
- Ucp2
uncoupling protein 2
- VEGF
vascular endothelial growth factor
- WT
wild type
References
- 1.Ahmad S, Hewett PW, Wang P, Al-Ani B, Cudmore M, Fujisawa T, Haigh JJ, et al. Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res. 2006;99:715–722. doi: 10.1161/01.RES.0000243989.46006.b9. [DOI] [PubMed] [Google Scholar]
- 2.Ambati S, Kim H-K, Yang J, Lin J, Della-Fera M, Baile C. Effects of leptin on apoptosis and adipogenesis in 3T3-L1 adipocytes. Biochem Pharmacol. 2007;73:378–384. doi: 10.1016/j.bcp.2006.10.009. [DOI] [PubMed] [Google Scholar]
- 3.Chinen I, Shimabukuro M, Yamakawa K, Higa N, Matsuzaki T, Noguchi K, Ueda S, et al. Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats. Endocrinology. 2007;148:160–165. doi: 10.1210/en.2006-1132. [DOI] [PubMed] [Google Scholar]
- 4.Clarke SD, Thuillier P, Baillie RA, Sha X. Peroxisome proliferator-activated receptors: a family of lipidactivated transcription factors. Am J Clin Nutr. 1999;70:566–571. doi: 10.1093/ajcn/70.4.566. [DOI] [PubMed] [Google Scholar]
- 5.Dembinska-Kiec A, Dulak J, Partyka L, Krzesz R, Dudek D, Bartus S, Polus M, et al. Induction of nitric oxide synthase (NOS) and vascular endothelial growth factor (VEGF) in experimental model of angioplasty and heart ischemia. Adv Exp Med Biol. 1997;433:163–167. doi: 10.1007/978-1-4899-1810-9_33. [DOI] [PubMed] [Google Scholar]
- 6.Fève B. Adipogenesis: cellular and molecular aspect. Best Pract Res Clin Endocrinol Metab. 2005;19:483–499. doi: 10.1016/j.beem.2005.07.007. [DOI] [PubMed] [Google Scholar]
- 7.Gupta K, Zhang J. Angiogenesis: a curse or cure. Postgrad Med J. 2005;81:236–242. doi: 10.1136/pgmj.2004.023309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab. 2004;89:4963–4971. doi: 10.1210/jc.2004-0305. [DOI] [PubMed] [Google Scholar]
- 9.Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000;49:1939–1945. doi: 10.2337/diabetes.49.11.1939. [DOI] [PubMed] [Google Scholar]
- 10.Kawasaki S, Hasegawa O, Satoh S, Saito T, Ishio H, Fukushima H, Kato S, et al. Development and progression of retinopathy after inpatient management of diabetes. Intern Med. 2006;45:1267–1271. doi: 10.2169/internalmedicine.45.1620. [DOI] [PubMed] [Google Scholar]
- 11.Kiec-Wilk B, Dembinska-Kiec A, Olszanecka A, Bodzioch M, Kawecka-Jaszcz K. The selected pathophysiological aspects of PPARs activation. J Physiol Pharmacol. 2005;56:149–162. [PubMed] [Google Scholar]
- 12.Kim KY, Cheon HG. Antiangiogenic effect of rosiglitazone is mediated via peroxisome proliferator-activated receptor y-activated maxi-K channel opening in human umbilical vein endothelial cells. J Biol Chem. 2006;281:13503–13512. doi: 10.1074/jbc.M510357200. [DOI] [PubMed] [Google Scholar]
- 13.Kraml P, Syrovatka P, Stipek S, Fialova L, Koprivova H, Potockova J, Andel M. Hyperlipoproteinemia impairs endothelium-dependent vasodilation. Physiol Res. 2004;53:471–480. [PubMed] [Google Scholar]
- 14.Lee TS, Saltsman KA, Ohashi H, King GL. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA. 1989;86:5141–5145. doi: 10.1073/pnas.86.13.5141. [DOI] [PMC free article] [PubMed] [Google Scholar] [Research Misconduct Found]
- 15.Massiera F, Saint-Marc P, Seydoux J, Murata T, Kobayashi T, Narumiya S, Guesnet P, et al. Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern. J Lipid Res. 2003;44:271–279. doi: 10.1194/jlr.M200346-JLR200. [DOI] [PubMed] [Google Scholar]
- 16.Matsumoto T, Mugishima H. Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis. J Atheroscler Thromb. 2006;13:130–135. doi: 10.5551/jat.13.130. [DOI] [PubMed] [Google Scholar]
- 17.McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139:802–809. doi: 10.7326/0003-4819-139-10-200311180-00007. [DOI] [PubMed] [Google Scholar]
- 18.Nishimura S, Manabe I, Nagasaki M, Hosoya Y, Yamashita H, Fujita H, Ohsugi M, et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes. 2007;56:1517–1526. doi: 10.2337/db06-1749. [DOI] [PubMed] [Google Scholar]
- 19.Oliveros LB, Videla AM, Gimenez MS. Effect of dietary fat saturation on lipid metabolism, arachidonic acid turnover and peritoneal macrophage oxidative stress in mice. Braz J Med Biol Res. 2004;37:311–320. doi: 10.1590/s0100-879x2004000300004. [DOI] [PubMed] [Google Scholar]
- 20.Papetti M, Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol. 2002;282:947–970. doi: 10.1152/ajpcell.00389.2001. [DOI] [PubMed] [Google Scholar]
- 21.Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE, Jang Y, et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med. 2001;33:95–102. doi: 10.1038/emm.2001.17. [DOI] [PubMed] [Google Scholar]
- 22.Parvanova A, Iliev I, Filipponi M, Dimitrov BD, Vedovato M, Tiengo A, Trevisan R, et al. Insulin resistance and proliferative retinopathy: a cross-sectional, case-control study in 115 patients with type 2 diabetes. J Clin Endocrinol Metab. 2004;89:4371–4376. doi: 10.1210/jc.2003-032076. [DOI] [PubMed] [Google Scholar]
- 23.Polverini PJ. Angiogenesis in health and disease: insights into basic mechanisms and therapeutic opportunities. J Dent Educ. 2002;66:962–975. [PubMed] [Google Scholar]
- 24.Scarfo LM, Weller PF, Farber HW. Induction of endothelial cell cytoplasmic lipid bodies during hypoxia. Am J Physiol Heart Circ Physiol. 2001;280:294–301. doi: 10.1152/ajpheart.2001.280.1.H294. [DOI] [PubMed] [Google Scholar]
- 25.Stitt AW, Curtis TM. Advanced glycation and retinal pathology during diabetes. Pharmacol Rep. 2005;57:156–168. [PubMed] [Google Scholar]
- 26.Sun XM, Bratton SB, Butterworth M, MacFarlane M, Cohen GM. Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J Biol Chem. 2002;277:11345–11351. doi: 10.1074/jbc.M109893200. [DOI] [PubMed] [Google Scholar]
- 27.Tei K, Kawakami-Kimura N, Taguchi O, Kumamoto K, Higashiyama S, Taniguchi N, Toda K, et al. Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats. Cancer Res. 2002;62:6289–6296. [PubMed] [Google Scholar]
- 28.Vidal-Puig A, Rosenbaum M, Considine RC, Leibel RL, Dohm GL, Lowell BB. Effects of obesity and stable weight reduction on UCP2 and UCP3 gene expression in humans. Obes Res. 1999;7:133–140. doi: 10.1002/j.1550-8528.1999.tb00694.x. [DOI] [PubMed] [Google Scholar]
- 29.Villarroya F, Iglesias R, Giralt M. Retinoids and retinoid receptors in the control of energy balance: novel pharmacological strategies in obesity and diabetes. Curr Med Chem. 2004;11:795–805. doi: 10.2174/0929867043455747. [DOI] [PubMed] [Google Scholar]
- 30.Vucenik I, Passaniti A, Vitolo MI, Tantivejkul K, Eggleton P, Shasuddin AM. Anti-angiogenic activity of inositol hexaphosphate (IP6) Carcinogenesis. 2004;11:2115–2123. doi: 10.1093/carcin/bgh232. [DOI] [PubMed] [Google Scholar]
- 31.Wan YJ, An D, Cai Y, Repa JJ, Hung-Po, Chen T, Flores M, et al. Hepatocyte-specific mutation establishes retinoid X receptor α as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol. 2000;20:4436–4444. doi: 10.1128/mcb.20.12.4436-4444.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Wan YJ, Cai Y, Lungo W, Fu P, Locker J, French S, Su-cov HM. Peroxisome proliferator-activated receptor α-mediated pathways are altered in hepatocyte-specific retinoid X receptor α-deficient mice. J Biol Chem. 2000;275:28285–28290. doi: 10.1074/jbc.M000934200. [DOI] [PubMed] [Google Scholar]
- 33.Wan YJ, Han G, Cai Y, Dai T, Konishi T, Leng AS. Hepatocyte retinoid X receptor-α-deficient mice have reduced food intake, increased body weight, and improved glucose tolerance. Endocrinology. 2003;144:605–611. doi: 10.1210/en.2002-221003. [DOI] [PubMed] [Google Scholar]
- 34.West CML, Cooper RA, Loncaster JA, Wilks DP, Bromley M. Tumor vascularity: a histological measure of angiogenesis and hypoxia. Cancer Res. 2001;61:2907–2910. [PubMed] [Google Scholar]
- 35.Zeng G, Gao L, Birkle S, Yu RK. Suppression of ganglioside GD3 expression in rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Cancer Res. 2000;23:6670–6676. [PubMed] [Google Scholar]




